[Form 4] Informatica Inc. Insider Trading Activity
Bruce R. Chizen, a director and chair of Informatica Inc. (INFA), reported option exercises and a sale on 09/02/2025. The filing shows multiple stock option exercises at strike prices of $8.70 and $10.00 that resulted in acquired shares of 23,863, 175,000, 17,727, and 30,000. On the same date 246,590 Class A shares were sold at $24.934 under a Rule 10b5-1 trading plan adopted December 4, 2024. Following the reported transactions the reporting person beneficially owns 368,874 Class A shares directly and 614,583 shares indirectly (held by the Gail Chizen 2009 Irrevocable Trust, where he is trustee). The exercised options were fully vested and exercisable, and certain option shares expire 10/31/2025.
- Transparent disclosure of option exercises, sale price, and 10b5-1 plan adoption date
- Substantial retained ownership: 368,874 shares directly and 614,583 shares indirectly reported following transactions
- Options fully vested and exercisable at disclosed strike prices ($8.70 and $10.00)
- Significant sale of 246,590 Class A shares at $24.934 occurred on the same date as exercises
- Concentration of indirect holdings in a family trust (614,583 shares), which may limit market liquidity of those shares
Insights
TL;DR: Routine insider option exercises and scheduled sales under a 10b5-1 plan, leaving substantial direct and indirect holdings.
The filing documents simultaneous option exercises and a contemporaneous sale executed pursuant to a Rule 10b5-1 plan. The reporter exercised options at $8.70 and $10.00 and sold 246,590 shares at $24.934. Post-transaction beneficial ownership remains material with 368,874 direct shares and 614,583 indirect shares via a family trust. This pattern—vested option exercise followed by a plan sale—is consistent with pre-arranged disposition rather than opportunistic trading. From a disclosure perspective, the form provides clear exercise prices, share counts, and the 10b5-1 adoption date, which supports transparency into the timing and mechanics of the transactions.
TL;DR: Disclosure is complete for reported transactions and confirms use of a pre-established trading plan.
The Form 4 identifies the reporting person as a director and chair and specifies that the sales were effected under a 10b5-1 plan adopted on December 4, 2024. It discloses fully vested options exercised on 09/02/2025 with expiration dates shown and the trust holding indirect shares. The filing includes signature and attestation, satisfying standard Section 16 reporting requirements. No amendments or missing required elements are evident in the provided content.